Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Granitor, formerly known as Midroc Europe, is a Swedish industrial group that provides specialized engineering and consultancy services to the life science, pharmaceutical, and healthcare sectors. The company specializes in the design, automation, and maintenance of complex production environments, ensuring compliance with stringent Good Manufacturing Practice (GMP) and cleanroom standards. Beyond its service offerings, the group's investment arm, Granitor New Technology, actively supports innovative startups in the medical technology and biotechnology sectors. In early 2022, the organization underwent a significant rebranding from Midroc Europe to Granitor to reflect its Nordic heritage and independent ownership structure. Today, the company serves as a critical infrastructure and technology partner for healthcare manufacturers across Northern Europe.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Midroc Europe.